Matthew Saldana has been a member of the UC Davis cancer research community for more than a decade and has contributed to the development of several NIH grants on diverse topics including RTK signal transduction, tumor metastasis, nanoparticle technology and tissue development. In addition, Dr. Saldana is experienced at manuscript preparation, review and submission.
A graduate of the UC Davis Integrative Pathobiology Graduate Program, Dr. Saldana’s thesis work in the laboratory of Kermit Carraway focused on understanding the molecular mechanisms of ErbB3 overexpression in breast cancer. His research also includes studies involving the ubiquitin-proteasome system, the synthesis of nanoparticles for membrane protein structure analysis and drug discovery, and the development of cell-based screening assays to identify protein-protein interaction networks. In addition to his graduate work, Dr. Saldana was the laboratory manager for Drs. Carraway and Colleen Sweeney at the UC Davis Comprehensive Cancer Center for nearly a decade. An enthusiastic teacher, Dr. Saldana is a guest lecturer for MCB257, a graduate-level cancer course. His cancer-related interests also include viral oncology, immuno-oncology and therapeutic discovery.